Daily AI-curated articles on clinical trials, FDA updates, and pharmaceutical insights.
B. Braun Medical recalls two lots of Lactated Ringer's Injection due to particulate contamination, raising critical concerns for clinical research protocols and patient safety.
Eli Lilly's ulcerative colitis study in Kissimmee represents evolving patient-centric recruitment strategies in gastroenterology research, offering insights for CROs.
ArchiMed's acquisition of Esperion Therapeutics signals strategic consolidation in cardiovascular drug development, potentially affecting ongoing clinical trials.
New RAPID pathway promises faster Medicare coverage for breakthrough medical devices, potentially transforming clinical research timelines and patient access strategies.
FDA issues recall alert for Trividia Health's TRUE METRIX glucose monitors due to E-5 error code potentially masking dangerous hyperglycemia in diabetic patients.
New clinical trial in Houston seeks participants with fatty liver disease, offering potential treatments while advancing research in this growing metabolic condition.
Novo Nordisk gains market advantage as Lilly's oral Foundayo faces slower-than-expected launch trajectory in the competitive oral GLP-1 weight-loss drug sector.
Executive Order directs HHS to fast-track treatments for serious mental illness, creating new pathways for clinical research in treatment-resistant conditions.
